Answers are grounded in this paper and cite their sources.
Demonstrates promising dual phototherapeutic effects in cancer cells, indicating potential treatment advances.
In this work, we report the facile aqueous synthesis of graphene oxide-FeZnCuInS/ZnS (GO-FeZCIS/ZnS) nanocomposite as a potential dual phototherapeutic agent. The as-synthesised nanocomposite showed a photoluminescence quantum yield (PLQY) higher than that of the undoped QDs and a superior average lifetime. The structural characterisations showed that the nanocomposite was negatively charged (− 40.40 mV) and quasi-spherical, with an average diameter of 33.09 nm. The XRD results revealed that the nanocomposite exhibits a zinc blend structure. The cytotoxicity assay against KM-Luc /GFP malignant fibrous histiocytoma-like cells stably expressing the firefly luciferase gene (KM-Luc) and Breast carcinoma cells (FM3A-Luc) showed that the materials are biocompatible, while the photothermal profiling analysis showed that the material was able to generate a lot of heat with a temperature change of about 45.2 °C which was higher than that of ZnCuInS/ZnS (ZCIS/ZnS) (35.5 °C) and FeZnCuInS/ZnS (FeZCIS/ZnS) (39.3 °C) QDs with singlet oxygen quantum yield of 0.27. The results showed the as-synthesised nanocomposite as a promising therapeutic agent for dual cancer phototherapy.
No takes yet. Share an insight, caveat, or question.
Mgedle et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: